Barely Significant
← all excerpts

Silibinin Suppresses Tumor Cell-Intrinsic Resistance to Nintedanib and Enhances Its Clinical Activity in Lung Cancer.

Cancers (Basel) · 2021 · PMC8394850 · PMID 34439322

Europe PMCDOI
2
hedged sentences
0.1000
closest p · 2.0× alpha
0.1000
boldest claim

The sentences

did not reach statistical significancep = 0.100so close (0.05 < p ≤ 0.1)
7.0 months 95%CI: 0.0–15.2 in KRAS -wild-type; p = 0.100), this trend in OS2L did not reach statistical significance ( p = 0.100; Figure S8 ).

also in 111,027 other papers

highly significantno p-value reported
Accordingly, highly significant, supra-additive increases in cell doubling times were observed in those cells simultaneously exposed to nintedanib and silibinin ( Figure S7 , bottom panels ). 2.8.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.